The DOI matches its Crossref record; 299 of the 299 references it cites were found in a registry or an index.
Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies
Abstract
Standard cancer therapies sometimes fail to deliver chemotherapeutic drugs to tumor cells in a safe and effective manner. Nanotechnology takes the lead in providing new therapeutic options for cancer due to major potential for selective targeting and controlled drug release. Antibodies and antibody fragments are attracting much attention as a source of targeting ligands to bind specific receptors that are overexpressed on cancer cells. Therefore, researchers are devoting time and effort to develop targeting strategies based on nanoparticles functionalized with antibodies, which hold great promise to enhance therapeutic efficacy and circumvent severe side effects. Several methods have been described to immobilize antibodies on the surface of nanoparticles. However, selecting the most appropriate for each application is challenging but also imperative to preserve antigen binding ability and yield stable antibody-conjugated nanoparticles. From this perspective, we aim to provide considerable knowledge on the most widely used methods of functionalization that can be helpful for decision-making and design of conjugation protocols as well. This review summarizes adsorption, covalent conjugation (carbodiimide, maleimide and "click" chemistries) and biotin-avidin interaction, while discussing the advantages, limitations and relevant therapeutic approaches currently under investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–299 of 299
Lee, Y. (2008) · Molecular BioSystems · doi:10.1039/b801810c · Cited by 82
Bahou, C., Richards, D. A., Maruani, A., Love, E. A., Javaid, F., Caddick, S., Baker, J. R., & Chudasama, V. (2018) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob03138f · Cited by 80
Targeting murine leukemic stem cells by antibody functionalized mesoporous silica nanoparticles
Mandal, T., Beck, M., Kirsten, N., Lindén, M., & Buske, C. (2018) · Scientific Reports · doi:10.1038/s41598-017-18932-4 · Cited by 79
Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy
Chu, I., Tseng, S., & Chou, M. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s80134 · Cited by 77
Pretargeted Imaging and Radioimmunotherapy of Cancer Using Antibodies and Bioorthogonal Chemistry
van de Watering, F. C. J., Rijpkema, M., Robillard, M. S., Oyen, W. J. G., & Boerman, O. C. (2014) · Frontiers in Medicine · doi:10.3389/fmed.2014.00044 · Cited by 76
Stefanick, J. F., Omstead, D. T., Kiziltepe, T., & Bilgiçer, B. (2019) · Nanoscale · doi:10.1039/c8nr09431d · Cited by 75
Homogeneous antibody fragment conjugation by disulfide bridging introduces ‘spinostics’
Schumacher, F. F., Sanchania, V. A., Tolner, B., Wright, Z. V. F., Ryan, C. P., Smith, M. E. B., Ward, J. M., Caddick, S., Kay, C. W. M., Aeppli, G., et al. (2013) · Scientific Reports · doi:10.1038/srep01525 · Cited by 73
Kolodych, S., Koniev, O., Baatarkhuu, Z., Bonnefoy, J., Debaene, F., Cianférani, S., DORSSELAER, A. V., & Wagner, A. (2015) · Bioconjugate Chemistry · doi:10.1021/bc500610g · Cited by 73
Antibody-Targeted Nanoparticles for Cancer Treatment
Carter, T. J., Mulholland, P. J., & Chester, K. A. (2016) · Immunotherapy · doi:10.2217/imt.16.11 · Cited by 73
Therapeutic Targeting in Nanomedicine: the Future Lies in Recombinant Antibodies
Pietersz, G. A., Wang, X., Yap, M. L., Lim, B., & Peter, K. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0043 · Cited by 72
Son, S., Shin, S., Rao, N. V., Um, W., Jeon, J., Ko, H., Deepagan, V. G., Kwon, S., Lee, J. Y., & Park, J. H. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.10.113 · Cited by 72
Site-specific chelator-antibody conjugation for PET and SPECT imaging with radiometals
Morais, M., & Ma, M. (2018) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2018.10.002 · Cited by 72
Adams, R., Griffin, L., Compson, J. E., Jairaj, M., BAKER, T. S., Ceska, T., West, S. M., Zaccheo, O., Davé, E., Lawson, A. D. G., et al. (2016) · mAbs · doi:10.1080/19420862.2016.1185581 · Cited by 71
Yang, W., Hu, Q., Xu, Y., Liu, H., & Zhong, L. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.04.011 · Cited by 69
Process Scale Purification of Antibodies
Gottschalk, U. 1. (2017) · Wiley eBooks · doi:10.1002/9781119126942 · Cited by 69
A Perspective on the Structure and Receptor Binding Properties of Immunoglobulin G Fc
Hanson, Q., & Barb, A. W. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00299 · Cited by 68
Qian, C., Wang, Y., Chen, Y., Zeng, L., Zhang, Q., Shuai, X., & Huang, K. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.056 · Cited by 67
Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII
Lu, L., Ding, Y., Zhang, Y., Ho, R. J. Y., Zhao, Y., Zhang, T., & Guo, C. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s153107 · Cited by 67
Near-infrared quantum dots for HER2 localization and imaging of cancer cells
Seifalian, A. M., Rizvi, S. B., Rouhi, S., et al. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s51535 · Cited by 66
Varshosaz, J., Davoudi, M. A., & Rasoul‐Amini, S. (2017) · Journal of Liposome Research · doi:10.1080/08982104.2017.1370471 · Cited by 66
Homogeneous antibody-drug conjugates via site-selective disulfide bridging
Forte, N., Chudasama, V., & Baker, J. R. (2018) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2018.09.004 · Cited by 66
A platform for efficient, thiol-stable conjugation to albumin's native single accessible cysteine
Smith, M. E. B., Caspersen, M. B., Robinson, E., Morais, M., Maruani, A., Nunes, J. P. M., Nicholls, K., Saxton, M. J., Caddick, S., Baker, J. R., et al. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob01205h · Cited by 65
VEGF- and VEGFR2-Targeted Liposomes for Cisplatin Delivery to Glioma Cells
Shein, S. A., Kuznetsov, I. I., Abakumova, T. O., Chelushkin, P. S., Melnikov, P., Korchagina, A. A., Bychkov, D. A., Seregina, I. F., Bolshov, M. A., Kabanov, A. V., et al. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00519 · Cited by 65
Zhu, R., Wang, Z., Liang, P., He, X., Zhuang, X., Huang, R., Wang, M., Wang, Q., Qian, Y., & Wang, S. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.09.009 · Cited by 65
Tang, X., Chen, L., Li, A., Cai, S., Zhang, Y., Liu, X., Jiang, Z., Liu, X., Liang, Y., & Ma, D. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1477859 · Cited by 64
Forte, N., Livanos, M., Miranda, E., Morais, M., Yang, X., Rajkumar, V. S., Chester, K. A., Chudasama, V., & Baker, J. R. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00795 · Cited by 64
Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools
Farahavar, G., Abolmaali, S. S., Gholijani, N., & Nejatollahi, F. (2019) · Biomaterials Science · doi:10.1039/c9bm00931k · Cited by 64
Dovgan, I., Kolodych, S., Koniev, O., & Wagner, A. (2016) · Scientific Reports · doi:10.1038/srep30835 · Cited by 62
A selective fluorescent probe for thiols based on α,β-unsaturated acyl sulfonamide
Zhang, H., WANG, P. H., Yang, Y., & Sun, H. (2012) · Chemical Communications · doi:10.1039/c2cc35513b · Cited by 61
Pretargeted PET Imaging of trans -Cyclooctene-Modified Porous Silicon Nanoparticles
Keinänen, O. M., Mäkilä, E. M., Lindgren, R., Virtanen, H. E., Liljenbäck, H., Oikonen, V., Sarparanta, M. P., Molthoff, C. F. M., Windhorst, A. D., Roivainen, A., et al. (2017) · ACS Omega · doi:10.1021/acsomega.6b00269 · Cited by 61
Understanding and utilizing the biomolecule/nanosystems interface
Chen, E. Y., Liu, W. F., Megido, L., Díez, P., Fuentes, M., Fager, C., Olsson, E., Gessner, I., & Mathur, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48063-5.00003-4 · Cited by 60
Taheri, A., Dinarvand, R., Atyabi, F., Ghahremani, M. H., & Ostad, S. N. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.06.016 · Cited by 59
CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment
Zhang, Q., Hu, X., Liu, Y.-L., Ye, Z.-J., Gui, Y.-H., Zhou, D., Qi, C., He, X., Wang, H., & Wang, L. (2015) · Scientific Reports · doi:10.1038/srep15948 · Cited by 59
Biotin decorated PLGA nanoparticles containing SN-38 designed for cancer therapy
Mehdizadeh, M., Rouhani, H., Sepehri, N., Varshochian, R., Ghahremani, M. H., Amini, M., Gharghabi, M., Ostad, S. N., Atyabi, F., Baharian, A., et al. (2016) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2016.1178130 · Cited by 59
An exploration of nucleic acid liquid biopsy using a glucose meter
Gu, Y., Zhang, T., Huang, Z., Hu, S., Zhao, W., Xu, J., & Chen, H. (2018) · Chemical Science · doi:10.1039/c8sc00627j · Cited by 59
A flow platform for degradation-free CuAAC bioconjugation
Hatit, M. Z. C., Reichenbach, L. F., Tobin, J. M., Vilela, F., Burley, G. A., & Watson, A. J. B. (2018) · Nature Communications · doi:10.1038/s41467-018-06551-0 · Cited by 59
Gao, S., Ding, D., & Gao, S. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s24094 · Cited by 55
Zhang, Y., Guo, J., Zhang, X., Li, D., Zhang, T., Gao, F., Liu, N., & Sheng, X. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.10.080 · Cited by 54
Functionalization of gold nanoparticles with nanobodies through physical adsorption
Goossens, J., Sein, H., Lu, S., Radwanska, M., Muyldermans, S., Sterckx, Y. G. ‐., & Magez, S. (2017) · Analytical Methods · doi:10.1039/c7ay00854f · Cited by 54
Duan, D., Wang, A., Ni, L., Zhang, L., Yan, X., Jiang, Y., Mu, H., Wu, Z., Sun, K., & Li, Y. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s153795 · Cited by 54
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity
Gabrielli, E., Pericolini, E., Cenci, E., Federica, O., Magliani, W., Ciociola, T., Bistoni, F., Conti, S., Vecchiarelli, A., & Polonelli, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008187 · Cited by 53
Quest for Efficacious Next-Generation Taxoid Anticancer Agents and Their Tumor-Targeted Delivery
Ojima, I., Wang, X., Jing, Y., & Wang, C. (2018) · Journal of Natural Products · doi:10.1021/acs.jnatprod.7b01012 · Cited by 53
Development of a novel antibody–tetrazine conjugate for bioorthogonal pretargeting
Maggi, A., Ruivo, E. F. P., Fissers, J., Vangestel, C., Chatterjee, S., Joossens, J., Sobott, F., Staelens, S. G., Stroobants, S. G., der Veken, P. V., et al. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob01411a · Cited by 52
Chemical cross-linking in the structural analysis of protein assemblies
Feixia Chu, C., Thornton, D. T., & Nguyen, H. T. (2018) · Methods · doi:10.1016/j.ymeth.2018.05.023 · Cited by 52
Nag, O. K., Yadav, V. R., Hedrick, A. F., & Awasthi, V. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.026 · Cited by 51
Impact of Antigen Density on the Binding Mechanism of IgG Antibodies
Hadzhieva, M., Pashov, A. D., Kaveri, S. V., Lacroix‐Desmazes, S., Mouquet, H., & Dimitrov, J. D. (2017) · Scientific Reports · doi:10.1038/s41598-017-03942-z · Cited by 51
The Emerging Role of Tetrazines in Drug‐Activation Chemistries
Neumann, K., Gambardella, A., & Bradley, M. (2018) · ChemBioChem · doi:10.1002/cbic.201800590 · Cited by 51
FDA and Nanotech: Baby Steps Lead to Regulatory Uncertainty
Bawa, R. (2013) · Wiley eBooks · doi:10.1002/9781118451915.ch41 · Cited by 50
A collagen-binding EGFR antibody fragment targeting tumors with a collagen-rich extracellular matrix
Liang, H., Li, X., Wang, B., Chen, B., Zhao, Y., Sun, J., Zhuang, Y., Shi, J., Shen, H., Zhang, Z., et al. (2016) · Scientific Reports · doi:10.1038/srep18205 · Cited by 50
Engineered IgG1‐Fc – one fragment to bind them all
Laurent, E., Traxlmayr, M. W., Obinger, C., & Hasenhindl, C. (2016) · Immunological Reviews · doi:10.1111/imr.12385 · Cited by 50
Zhu, R., Zhang, C.-G., Liu, Y., Yuan, Z.-Q., Chen, W., Yang, S.-D., Li, J., Zhu, W.-J., Zhou, X., You, B., et al. (2015) · Scientific Reports · doi:10.1038/srep17904 · Cited by 50
Multidentate Polysarcosine-Based Ligands for Water-Soluble Quantum Dots
Fokina, A., Klinker, K., Braun, L., Jeong, B. G., Bae, W. K., Barz, M., & Zentel, R. (2016) · Macromolecules · doi:10.1021/acs.macromol.6b00582 · Cited by 49
Hermanson, G. T. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-382239-0.00005-4 · Cited by 48
Yang, Z., Wong, B. C. K., Zhang, H., Qin, L., Chen, H., Lü, A., & Chen, F. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s63235 · Cited by 47
Bioconjugation in Drug Delivery: Practical Perspectives and Future Perceptions
Elzahhar, P. A., Belal, A. S. F., ElAmrawy, F., Helal, N. A., & Nounou, M. I. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9516-5_11 · Cited by 47
Monterrubio, C., Paco, S., Olaciregui, N. G., Pascual‐Pasto, G., Vilà-Ubach, M., Cuadrado‐Vilanova, M., Ferrandiz, M. M., Castillo‐Ecija, H., Glisoni, R. J., Kuplennik, N., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.016 · Cited by 46
Nanotechnologies in Preventive and Regenerative Medicine
(2017) · Elsevier eBooks · doi:10.1016/c2016-0-00418-7 · Cited by 46
Techniques for the Analysis of Cysteine Sulfhydryls and Oxidative Protein Folding
Borges, C. R., & Sherma, N. D. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5559 · Cited by 45
Jiang, S., Wang, X., Zhang, Z., Sun, L., Pu, Y., Yao, H.-J., Li, J., Liu, Y., Zhang, Y., & Zhang, W. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s115428 · Cited by 45
Choi, J., Jang, W. S., & Park, J. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.06.059 · Cited by 43
Wei, J. S., Sun, J., & Liu, Y. (2019) · Oncology Letters · doi:10.3892/ol.2019.10050 · Cited by 42
A Simple Method for Enhancing the Bioorthogonality of Cyclooctyne Reagent
Tian, H., Sakmar, T., & Huber, T. (2016) · Chemical Communications · doi:10.1039/c6cc01321j · Cited by 41
In Vivo Fate of Avidin-Nucleic Acid Nanoassemblies as Multifunctional Diagnostic Tools
Bigini, P., Previdi, S., Casarin, E., Silvestri, D., Violatto, M. B., Facchin, S., Sitia, L., Rosato, A., Zuccolotto, G., Realdon, N., et al. (2013) · ACS Nano · doi:10.1021/nn402669w · Cited by 39
Controlled Fab installation onto polymeric micelle nanoparticles for tuned bioactivity
Chen, S., Florinas, S., Teitgen, A. E., Xu, Z.-Q., Gao, C., Wu, H., Kataoka, K., Cabral, H., & Christie, R. J. (2017) · Science and Technology of Advanced Materials · doi:10.1080/14686996.2017.1370361 · Cited by 39
Storage stability of electrospun pure gelatin stabilized with EDC/Sulfo‐NHS
Ghassemi, Z., & Slaughter, G. E. (2018) · Biopolymers · doi:10.1002/bip.23232 · Cited by 38
High efficiency reduction capability for the formation of Fab׳ antibody fragments from F(ab)2 units
Crivianu-Gaita, V., Romaschin, A. D., & Thompson, M. E. (2015) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2015.04.004 · Cited by 37
Malaspina, D. C., Longo, G. S., & Szleifer, I. G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185518 · Cited by 37
Robotham, A. C., & Kelly, J. F. (2019) · mAbs · doi:10.1080/19420862.2019.1595307 · Cited by 37
Sorci, M., Dassa, B., Liu, H., Anand, G., Dutta, A. K., Pietrokovski, S., Belfort, M., & Belfort, G. (2013) · Analytical Chemistry · doi:10.1021/ac400949t · Cited by 35
Gholizadeh, S., Dolman, M. E. M., Wieriks, R., Sparidans, R. W., Hennink, W. E., & Kok, R. J. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2373-x · Cited by 35
Vadlapudi, A. D., Vadlapatla, R. K., Pal, D., & Mitra, A. K. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9399-5 · Cited by 33
Yang, Q., Parker, C. L., McCallen, J., & Lai, S. K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.040 · Cited by 33
Spahr, C. S., Shi, S. D. ‐., & Lu, H. S. (2014) · mAbs · doi:10.4161/mabs.28763 · Cited by 30
Krkavcová, E., Kreisinger, J., Hyánková, L., Hyršl, P., & Javůrková, V. (2018) · Biology Open · doi:10.1242/bio.031518 · Cited by 30
Verdoliva, A., Bellofiore, P., Rivieccio, V., Catello, S., Colombo, M., Albertoni, C., Rosi, A., Leoni, B., Anastasi, A. M., & Santis, R. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.080457 · Cited by 29
A pretargeted nanoparticle system for tumor celllabeling
Gunn, J., Park, S. I., Omid Veiseh, A., Press, O. W., & Zhang, M. (2010) · Molecular BioSystems · doi:10.1039/c005154c · Cited by 29
Xiong, J., Han, S., Ding, S., He, J., & Zhang, H. (2018) · Oncology Reports · doi:10.3892/or.2018.6201 · Cited by 29
Guo, J., Luan, X., Cong, Z., Sun, Y., Wang, L., McKenna, S. L., Cahill, M. R., & O’Driscoll, C. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.024 · Cited by 27
Vedakumari, S. W., Senthil, R., Sekar, S., Chidambaram, S. B., & Sastry, T. P. (2018) · Materials Chemistry and Physics · doi:10.1016/j.matchemphys.2018.11.061 · Cited by 23
Role of FcγRs in Antibody-Based Cancer Therapy
Graziano, R. F., & Engelhardt, J. (2019) · Current topics in microbiology and immunology · doi:10.1007/82_2019_150 · Cited by 23
Baiu, D. C., Artz, N. S., McElreath, M. R., Menapace, B. D., Hernando, D., Reeder, S. B., Grüttner, C., & Otto, M. (2015) · Nanomedicine · doi:10.2217/nnm.15.138 · Cited by 21
Groves, M. A. T., Amanuel, L., Campbell, J. I., Rees, D. G., Sridharan, S., Finch, D. K., Lowe, D. C., & Vaughan, T. J. (2013) · mAbs · doi:10.4161/mabs.27261 · Cited by 20
Li, Y.-W. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i14.4275 · Cited by 20
Chaudhary, S., Smith, C. A., del Pino, P., de la Fuente, J. M., Mullin, M., Hursthouse, A. S., Stirling, D., & Berry, C. C. (2013) · Pharmaceuticals · doi:10.3390/ph6020204 · Cited by 19
Kellmann, S.-J., Dübel, S., & Thie, H. (2017) · mAbs · doi:10.1080/19420862.2016.1277302 · Cited by 19
Bu, J., Zhou, P., Zhao, F., & McLuckey, S. A. (2017) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-017-1613-3 · Cited by 18
Yang, Q., Parker, C. L., Lin, Y., Press, O. W., Park, S. I., & Lai, S. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.388 · Cited by 18
Parracino, M. A., Martín-Gracia, B., & Grazú, V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814531-9.00009-9 · Cited by 17
Bioinspired Approaches for Human-Centric Technologies
Assad, J. A., Berdondini, L., Cancedda, L., Angelis, F. D., Dipalo, M., Fellin, T., Maccione, A., Panzeri, S., Sileo, L., & Diaspro, A. (2014) · Springer eBooks · doi:10.1007/978-3-319-04924-3 · Cited by 15
Tienken, L., Drude, N., Schau, I., Winz, O., Temme, A., Weinhold, E. G., Mottaghy, F. M., & Morgenroth, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-22179-y · Cited by 13
HPMA-Based Nanoparticles for Fast, Bioorthogonal iEDDA Ligation
Kramer, S., Svatunek, D., Alberg, I., Gräfen, B., Schmitt, S., Braun, L., van Onzen, A. H. A. M., Rossin, R., Koynov, K., Mikula, H., et al. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b00868 · Cited by 13
Application of Next-Generation Maleimides (NGMs) to Site-Selective Antibody Conjugation
Morais, M., Forte, N., Chudasama, V., et al. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9654-4_2 · Cited by 12
Thomann, S., Baek, S., & Ryschich, E. (2015) · Oncotarget · doi:10.18632/oncotarget.5662 · Cited by 11
Gascón, V., Márquez‐Álvarez, C., Dı́az, I., & Blanco, R. M. (2016) · Wiley eBooks · doi:10.1002/9781119113874.ch19 · Cited by 11
Ding, B., Zhang, W., Wu, X., Wang, J., Xie, C., Huang, X., Zhan, S., Zheng, Y., Huang, Y., Xu, N., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11014 · Cited by 10
Parker, C. L., Yang, Q., Yang, B., McCallen, J., Park, S. I., & Lai, S. K. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.08.049 · Cited by 9
Synthetic Methodology in Chemical Biology
Brewster, R. C., & Wallace, S. (2019) · Wiley eBooks · doi:10.1002/9781119483977.ch8 · Cited by 2
Kumar, A., White, J., Christie, R. J., Dimasi, N., & Gao, C.-S. (2017) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2017.08.002 · Cited by 1
Kolb (2001) · doi:10.1002/1521-3773(20010601)40:11<2004::aid-anie2004>3.0.co;2-5
Cited by
Nanomedicine in cancer therapy
Fan, D., Cao, Y., Cao, M., Wang, Y., Cao, Y., & Gong, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01536-y · Cited by 878
Nanoparticles in Clinical Translation for Cancer Therapy
Mundekkad, D., & Cho, W. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031685 · Cited by 305
Billingsley, M. M., Gong, N., Mukalel, A. J., Thatte, A. S., El‐Mayta, R., Patel, S. K., Metzloff, A. E., Swingle, K. L., Han, X., Xue, L., et al. (2024) · Small · doi:10.1002/smll.202304378 · Cited by 268
Advancing engineering design strategies for targeted cancer nanomedicine
Gomerdinger, V. F., Nabar, N., & Hammond, P. T. (2025) · Nature Reviews Cancer · doi:10.1038/s41568-025-00847-2 · Cited by 146
The impact of protein corona on the biological behavior of targeting nanomedicines
Farshbaf, M., Valizadeh, H., Panahi, Y., Fatahi, Y., Chen, M., Zarebkohan, A., & Gao, H. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121458 · Cited by 95
Metadata
- Authors
- Marques, A. C., Costa, P. J., Velho, S., & Amaral, M. H.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 320
- Pages
- 180-200
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W3001632525
- Cited by
- 349
- References
- 299
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.